Devonian Health Group Inc's stock has seen significant fluctuations recently, particularly over the past week.
Devonian Health Group Inc (GSD.V) closed at C$9.00, unchanged on the day but down 18.45% over the past week. This performance comes amidst various corporate developments that may be influencing investor sentiment.
Advertisement
Devonian Health Group Inc
GSD.V
GSD.V
Devonian Health Group Inc
WealthAwesomeMarket cap
$22.25M
52W high
$15.00
52W low
$0.19
1W change
-18.45%
Beta
1.24
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GSD's historical volatility
30-Day Vol
226.5%
Annualized
90-Day Vol
196.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$6.69
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$7.54 | C$3.45 – C$16.47 |
| 60 trading days | C$7.10 | C$2.35 – C$21.44 |
| 90 trading days | C$6.69 | C$1.73 – C$25.90 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should pay attention to Devonian's recent financial results and strategic plans, including its anticipated NYSE American listing, as these factors could impact future stock performance. Understanding the company's technical indicators and market position is crucial for making informed decisions.
C$9.00 closing price, reflecting a 0.00% change today.
Devonian's stock has seen a substantial decline of 29.82% year-to-date, indicating challenges in maintaining investor confidence.
Bull case
The planned NYSE American listing could boost visibility and attract institutional investors, which may drive future growth and help recover the stock price.
Bear case
The significant loss reported in the latest financial results, along with the recent drop in stock price, raises concerns about the company's financial health and operational viability.
Recent Price Action
Advertisement
Devonian Health Group Inc (GSD.V) has closed at C$9.00, showing no change today. Over the past week, the stock has experienced a notable decline of 18.45%. In the broader view, the stock is down 29.82% year-to-date, reflecting ongoing challenges within the company.
Catalysts and Company News
Recent headlines highlight Devonian's plans to list on the NYSE American, which could provide a new avenue for capital and visibility. The company is also preparing for an underwritten public offering of its common shares and warrants, with trading expected to start as early as September 16, 2026. Additionally, Devonian received Health Canada authorization for a pediatric clinical trial of Thykamine™, a promising development for its product pipeline.
Technical Picture
From a technical standpoint, Devonian Health Group's stock is currently trading above its 50-day moving average of C$8.76, indicating short-term strength, but below its 200-day moving average of C$10.80, suggesting long-term weakness. The stock's 52-week range spans from C$0.19 to C$15.00, placing the current price at 59% of its range. The beta of 1.24 indicates that the stock is more volatile than the broader market. Recent trading volumes have been low, with only 123 shares changing hands against a 20-day average of 2,767 shares, reflecting reduced investor interest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
